Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 10 February 2020, 15:00 HKT/SGT
Share:
    

Source: Meiogenix
Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies

Monheim, Germany and Paris, France, Feb 10, 2020 - (ACN Newswire) - Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix's proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops so farmers can more efficiently and sustainably grow improved plant varieties that deliver the types of foods consumers want.


Figure 1: Plants Genetic Diversity - To view an enhanced version of Figure 1, please visit: https://orders.newsfilecorp.com/files/6942/52265_3248f08fd41dbbdb_001full.jpg


"Farmers need innovative solutions as they face limited natural resources and a changing climate," said Jeremy Williams, Head of Plant Biotechnology, Crop Science Research & Development (R&D) at Bayer. "Access to Meiogenix's proprietary technologies could improve the precision and speed with which our breeders enhance crops, which could ultimately accelerate those solutions for the diverse needs of people and our planet."

Meiogenix's proprietary technologies are used to induce the exchange of genomic regions between chromosomes of plant cells during meiosis, the natural process that generates genetic diversity during plant breeding. Technologies based on meiotic recombination provide commercial crops with access to a broader genetic diversity, including complex traits for improved food quality, plants' resistance to diseases and pests, and higher yield potential. The resulting hybrids and varieties have the potential to deliver value throughout the food chain, from farmers to consumers.

"Over the past decade, we have assembled unique know-how, intellectual property portfolio and network of experts to help generate biodiversity and accelerate breeding through modulating meiotic recombination. We are proud to collaborate with Bayer to develop the next generations of crops," said Giacomo Bastianelli, Co-founder & CEO of Meiogenix.

"Agriculture is facing the challenge of adjusting plant physiology to rapid climate, pest and disease changes, as well as preparing the next generation of healthier food. Collaborating on these new breeding technologies will be key to bringing innovative solutions to farmers and consumers," said Luc Mathis, strategic advisor of Meiogenix.

As part of the project, Meiogenix will collaborate with top academic institutes to advance these technologies in crops.

Bayer offers a wide range of educational materials regarding plant breeding and gene editing technologies on its website.

Find more information at www.bayer.com and at www.meiogenix.com

Press Contact
Bayer: Holger Elfes, +49 2173 38-3270, [email protected]
Meiogenix: Caroline Carmagnol, +33 6 64 18 99 59, [email protected]

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Related Links
Meiogenix Technologies https://www.newsfilecorp.com/redirect/bL0xiyao
Breeding and gene editing at Bayer https://www.newsfilecorp.com/redirect/3ALgsvEX

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52265


Feb 10, 2020 15:00 HKT/SGT
Topic: Press release summary
Sectors: Agritech, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Oxford Medical Case shows Chiropractics can ease Dizziness and Neck Pain  
Feb 26, 2020 14:00 HKT/SGT
Rise of the World'S First Convertible Crypto Bond - The Name Is Bond, Comm'S Bond  
Feb 26, 2020 14:00 HKT/SGT
Fibocom Launches UNISOC 8910DM Powered LTE Cat.1 Module at Embedded World 2020  
Feb 26, 2020 11:28 HKT/SGT
Lexus' Electrification Drives Sensory Experience at Milan Design Week 2020  
Feb 25, 2020 17:27 HKT/SGT
4 Sharp Products Win 2020 iF Design Award  
Feb 25, 2020 16:37 HKT/SGT
BTS Takes Over Twitter with 17 Million Tweets in 48 Hours  
Feb 25, 2020 16:00 HKT/SGT
Mitsubishi Corporation and CRISP HD Agree to Business Alliance and Acquisition of Third-Party Shares  
Feb 25, 2020 14:16 HKT/SGT
COMM's New Project Launch Integrates Publisher and Hedge Funds on Blockchain  
Feb 25, 2020 12:55 HKT/SGT
Food Empire's FY2019 net profit jumps 44.9% to a record US$25.7 million  
Feb 25, 2020 11:00 HKT/SGT
Parkson Announces the Annual Results for the Year Ended 31 December 2019  
Feb 25, 2020 10:58 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: